Speaker illustration

Mrs Martina Arici

University of Milan Bicocca, Milan (Italy)

OR 09 - Istaroxime follow-on compounds: a new class of selective SERCA2a activators as first-in-class drug candidates for heart failure treatment

Event: 47th EWGCCE Meeting 2023

Topic: Cellular Electrophysiology

Session: Session 4: Pharmacology of Ion Channels


SERCA2a stimulation by istaroxime improves intracellular Ca2+ handling and diastolic dysfunction in a model of diabetic cardiomyopathy

Event: EHRA 2021

Topic: Cardiac Diseases

Session: ePoster session - WGCCE


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb